Literature DB >> 27813310

Identifying Axial Spondyloarthritis in Electronic Medical Records of US Veterans.

Jessica A Walsh1, Yijun Shao2, Jianwei Leng1, Tao He1, Chia-Chen Teng1, Doug Redd2, Qing Treitler Zeng2, Zachary Burningham3, Daniel O Clegg1, Brian C Sauer1.   

Abstract

OBJECTIVE: Large database research in axial spondyloarthritis (SpA) is limited by a lack of methods for identifying most types of axial SpA. Our objective was to develop methods for identifying axial SpA concepts in the free text of documents from electronic medical records.
METHODS: Veterans with documents in the national Veterans Health Administration Corporate Data Warehouse between January 1, 2005 and June 30, 2015 were included. Methods were developed for exploring, selecting, and extracting meaningful terms that were likely to represent axial SpA concepts. With annotation, clinical experts reviewed sections of text containing the meaningful terms (snippets) and classified the snippets according to whether or not they represented the intended axial SpA concept. With natural language processing (NLP) tools, computers were trained to replicate the clinical experts' snippet classifications.
RESULTS: Three axial SpA concepts were selected by clinical experts, including sacroiliitis, terms including the prefix spond*, and HLA-B27 positivity (HLA-B27+). With supervised machine learning on annotated snippets, NLP models were developed with accuracies of 91.1% for sacroiliitis, 93.5% for spond*, and 97.2% for HLA-B27+. With independent validation, the accuracies were 92.0% for sacroiliitis, 91.0% for spond*, and 99.0% for HLA-B27+.
CONCLUSION: We developed feasible and accurate methods for identifying axial SpA concepts in the free text of clinical notes. Additional research is required to determine combinations of concepts that will accurately identify axial SpA phenotypes. These novel methods will facilitate previously impractical observational research in axial SpA and may be applied to research with other diseases.
© 2016, American College of Rheumatology.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 27813310     DOI: 10.1002/acr.23140

Source DB:  PubMed          Journal:  Arthritis Care Res (Hoboken)        ISSN: 2151-464X            Impact factor:   4.794


  6 in total

1.  Incorporating natural language processing to improve classification of axial spondyloarthritis using electronic health records.

Authors:  Sizheng Steven Zhao; Chuan Hong; Tianrun Cai; Chang Xu; Jie Huang; Joerg Ermann; Nicola J Goodson; Daniel H Solomon; Tianxi Cai; Katherine P Liao
Journal:  Rheumatology (Oxford)       Date:  2020-05-01       Impact factor: 7.580

Review 2.  Epidemiology of axial spondyloarthritis: an update.

Authors:  Runsheng Wang; Michael M Ward
Journal:  Curr Opin Rheumatol       Date:  2018-03       Impact factor: 5.006

3.  Radiomic Quantification for MRI Assessment of Sacroiliac Joints of Patients with Spondyloarthritis.

Authors:  Ariane Priscilla Magalhães Tenório; José Raniery Ferreira-Junior; Vitor Faeda Dalto; Matheus Calil Faleiros; Rodrigo Luppino Assad; Paulo Louzada-Junior; Marcello Henrique Nogueira-Barbosa; Rangaraj Mandayam Rangayyan; Paulo Mazzoncini de Azevedo-Marques
Journal:  J Digit Imaging       Date:  2022-01-07       Impact factor: 4.056

Review 4.  Application of machine learning in the diagnosis of axial spondyloarthritis.

Authors:  Jessica A Walsh; Martin Rozycki; Esther Yi; Yujin Park
Journal:  Curr Opin Rheumatol       Date:  2019-07       Impact factor: 5.006

Review 5.  Natural Language Processing of Clinical Notes on Chronic Diseases: Systematic Review.

Authors:  Seyedmostafa Sheikhalishahi; Riccardo Miotto; Joel T Dudley; Alberto Lavelli; Fabio Rinaldi; Venet Osmani
Journal:  JMIR Med Inform       Date:  2019-04-27

Review 6.  Natural language processing in low back pain and spine diseases: A systematic review.

Authors:  Luca Bacco; Fabrizio Russo; Luca Ambrosio; Federico D'Antoni; Luca Vollero; Gianluca Vadalà; Felice Dell'Orletta; Mario Merone; Rocco Papalia; Vincenzo Denaro
Journal:  Front Surg       Date:  2022-07-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.